Key Highlights

  • Encompass Health's $0.21 quarterly dividend goes ex-dividend October 1, 2026 and is payable October 15, an increase of $0.02.
  • Second-quarter net operating revenue was $1.5974 billion, up 9.6% from $1.4577 billion a year earlier.
  • Diluted EPS from continuing operations attributable to Encompass Health was $1.55 versus $1.40.
  • Six-month net income was $455.6 million versus $381.4 million, with net income attributable to Encompass Health of $348.4 million.

Overview

Encompass Health Corporation's (NYSE:EHC) $0.21 quarterly dividend yields 0.68% and is $0.02 higher than the prior $0.19 rate. The board declared it on July 23, 2026, and it is payable October 15 to shareholders of record October 1. Second-quarter diluted EPS from continuing operations attributable to Encompass Health was $1.55, compared with $1.40 a year earlier.

Dividend Program and Shareholder Returns

Encompass Health's board declared a quarterly cash dividend of $0.21 per share on July 23, 2026, payable October 15 to shareholders of record on October 1. The amount is $0.02 higher than the prior $0.19 quarterly rate.

The company identifies no separate special or supplemental common dividend, and dividends remain subject to board approval.

About the Company

Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States. Its hospitals provide intensive rehabilitation to patients recovering from strokes, neurological conditions, orthopedic injuries, and brain and spinal-cord injuries. Patient volumes, admissions, discharges, reimbursement rates, case mix, hospital capacity and labor costs are the operating drivers its filings identify.

Financial Performance Behind the Payout

Encompass Health reported second-quarter net operating revenue of $1.5974 billion, up 9.6% from $1.4577 billion. GAAP net income was $207.4 million versus $184.9 million, and net income attributable to Encompass Health was $153.9 million versus $142.1 million.

Income from continuing operations rose 11.9% to $208.0 million. Diluted EPS from continuing operations attributable to Encompass Health was $1.55 versus $1.40. Operating expenses rose 9.2%.

For the first six months, GAAP net income was $455.6 million versus $381.4 million, and net income attributable to Encompass Health was $348.4 million versus $293.6 million. Adjusted EBITDA is reported separately as a non-GAAP measure.

Revenue Growth, Operating Expense Growth and the Dividend Increase

Second-quarter net operating revenue rose 9.6% while operating expenses rose 9.2%, with supplies, general and administrative expenses and depreciation all higher. Income from continuing operations rose 11.9%.

The $0.02 dividend increase was declared on July 23, 2026, before the company's August 5 second-quarter results. GAAP net income and non-GAAP adjusted EBITDA are reported separately in company filings and are not interchangeable measures.

Encompass Health continues to invest in its inpatient rehabilitation hospital network, and capital allocation includes hospital development alongside dividends.

Outlook

The company's filings identify patient volumes, admissions, discharges, reimbursement rates, case mix, hospital capacity and labor costs as the drivers of results. Second-quarter operating expenses rose 9.2% against net operating revenue growth of 9.6%, and each dividend declaration remains subject to board approval.